$3.42
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Accendra Health, Inc. engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. The company is headquartered in Glen Allen, Virginia and currently employs 6,500 full-time employees. Its Patient Direct segment includes home healthcare divisions (Byram and Apria). The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies and is a provider of integrated home healthcare equipment and related services in the United States. The company offers a range of products and services for in-home care and delivery, including diabetes treatment, home respiratory therapy (including home oxygen and non-invasive ventilation services), and obstructive sleep apnea treatment (including continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services). Additionally, it supplies a wide range of other home medical equipment, patient care product lines including ostomy, wound care (including negative pressure wound therapy), urology, incontinence and other products and services.
Country

US

CEO

Mr. Edward Pesicka

IPO date

1980

Employees

6,500

ISIN

US6907321029

Key stats

Open

$3.28

Volume

262.20K

Market cap

$261.92M

Prev. close

$3.42

Impl / hst vl

-

Open interest

$0.00

$3.27

Day’s Range

$3.48

$1.84

52W Range

$4.69

Valuation

27
Valuation score
Overvalued
P/E
-
P/S
0.10
P/B
-
Current ratio
0.49
Debt / Equity
-
ROE
-
Gross margin
44.29%
Income growth
-88.52%
FCF growth
-257.16

Dec

31

Dividends

The last payment date was Dec 31, 2021

Div. per Share

$0.00

Div. Yield

0.07%

Payout Ratio

0.33%

Div. Growth YoY

0.00%

Analysts estimates

Consensus rating
Sell

The average rating from top 6 analysts indicates that stock may slightly underperform the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$4.58
The top 6 analysts forecasts that 12-month price may increase by 33.91%, with a low of $2.73 and a high of $6.30
$2.73
Low
$4.58
Avg
$6.30
High
Current price

Earnings

Q1 ‘26 revenue
$627.78M
Q1 ‘26 net income
-$6.47M
Revenue
Net income
Previous EPS
-$0.04
Estimate EPS
-$0.09
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply